We are live on ! Find out more
SRPT icon

Sarepta Therapeutics
SRPT

149 hedge funds and large institutions have $891M invested in Sarepta Therapeutics in 2015 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 57 increasing their positions, 43 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

173% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 11

73% more call options, than puts

Call options by funds: $94.2M | Put options by funds: $54.3M

33% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 43

15% more funds holding

Funds holding: 130 → 149 (+19)

10% more capital invested

Capital invested by funds: $811M → $891M (+$80.6M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
149
Holders Change
+19
Holders Change %
+14.62%
% of All Funds
4.16%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
30
Increased
57
Reduced
43
Closed
11
Calls
$94.2M
Puts
$54.3M
Net Calls
+$39.9M
Net Calls Change
-$9.05M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$27.3M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$18.5M
3
Millennium Management
Millennium Management
New York
+$17.2M
4
ACA
Avoro Capital Advisors
New York
+$15.9M
5
OAM
Oxford Asset Management
United Kingdom
+$10.8M

Top Sellers

Rank Fund Capital Flow
1
CWAM
Columbia Wanger Asset Management
Illinois
-$47.5M
2
HM
HealthCor Management
New York
-$11.1M
3
State Street
State Street
Massachusetts
-$7.94M
4
Jennison Associates
Jennison Associates
New York
-$6.93M
5
Invesco
Invesco
Georgia
-$6.71M
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
151
Amici Capital
New York
– -$583K -19,150 Closed
QSS
152
Quantitative Systematic Strategies
Florida
– -$295K -10,291 Closed
PAM
153
Paradigm Asset Management
New York
– -$183K -6,000 Closed
KAM
154
Kazazian Asset Management
Florida
– -$134K -4,419 Closed
JT
155
Jump Trading
Illinois
– -$75K -2,462 Closed
CLOS
156
Compagnie Lombard Odier SCmA
Switzerland
– -$40K -1,300 Closed
BRWM
157
B. Riley Wealth Management
Tennessee
– -$24K -800 Closed
W
158
Wealthfront
California
– -$4K -127 Closed
DADC
159
D.A. Davidson & Co
Montana
– -$1K -46 Closed
3 4 5 6
7

SRPT Hedge Fund Activity: Q3 2015 in Review

149 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Sarepta Therapeutics (SRPT) for Q3 2015, worth a combined $891M — up 9.9% from $811M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new SRPT positions and 11 closed out — a net gain of 19 holders — while 57 added to existing stakes and 43 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $27.3M. The largest seller was Columbia Wanger Asset Management, cutting an estimated $47.5M.

  • 149 institutional investors held Sarepta Therapeutics (SRPT) as of Q3 2015, up from 130 in Q2 2015.
  • Funds reported $891M of Sarepta Therapeutics stock for Q3 2015, up 9.9% quarter-over-quarter.
  • 30 funds opened new Sarepta Therapeutics positions in Q3 2015 and 11 closed out, a net change of +19 holders.
  • The largest Sarepta Therapeutics buyer in Q3 2015 was Citadel Advisors, an estimated $27.3M added.
  • The largest Sarepta Therapeutics seller in Q3 2015 was Columbia Wanger Asset Management, an estimated $47.5M sold.

Based on aggregated 13F filings for Q3 2015.